THEODOR BILHARZ RESEARCH INSTITUTE

🇪🇬Egypt

Country: 🇪🇬Egypt

Ownership: -

Employees: -

Market Cap: -

Website: http://www.tbri.sci.eg/

Clinical Trials

New Technique of Pancreaticojejunostomy During Whipple Operation

Phase 4

Completed

Conditions: Periampullary Carcinoma Resectable
Pancreatic Tumors
Duodenal Neoplasms

Interventions: Procedure: Pancreaticojejunostomy without stenting and omental patch
Procedure: Pancreaticojejunostomy with stenting and omental patch

First Posted Date: 2024-10-08

Last Posted Date: 2024-10-08

Lead Sponsor: Theodor Bilharz Research Institute

Target Recruit Count: 48

Registration Number: NCT06630910

Locations: 🇪🇬
Theodor Bilharz Research Institute, Giza, Egypt

Using Indocyanine Green (ICG) to Outline Biliary Tree During Laparoscopic Cholecystectomy

Phase 4

Completed

Conditions: Chronic Calculous Cholecystitis
Laparoscopic Cholecystectomy

Interventions: Drug: Indocyanine Green Drug
Drug: Indocyanine Green

First Posted Date: 2024-10-07

Last Posted Date: 2024-10-07

Lead Sponsor: Theodor Bilharz Research Institute

Target Recruit Count: 60

Registration Number: NCT06629415

Locations: 🇪🇬
Theodor Bilharz Research Institute, Giza, Egypt

Dexmedetomidine for Attenuation of Pressor Response

Phase 4

Completed

Conditions: Pressor Response

Interventions: Drug: PRECEDEX INJ★ 2ML

First Posted Date: 2024-09-11

Last Posted Date: 2024-09-11

Lead Sponsor: Theodor Bilharz Research Institute

Target Recruit Count: 60

Registration Number: NCT06592027

Locations: 🇪🇬
Theodor Bilharz Research institute, Giza, Egypt

Postoperative Hypoxemia in Obese Patients

Not Applicable

Completed

Conditions: Atelectasis, Postoperative Pulmonary
Bariatric Surgery

Interventions: Other: Pressure Support Ventilation
Other: spontaneously assisted breathing

First Posted Date: 2024-09-10

Last Posted Date: 2024-09-10

Lead Sponsor: Theodor Bilharz Research Institute

Target Recruit Count: 170

Registration Number: NCT06589011

Locations: 🇪🇬
Theodor Bilharz Research institute, Giza, Cairo, Egypt

Lidocaine Versus Fentanyl for Hemodynamic Stability

Phase 4

Completed

Conditions: Hypertension
Fentanyl
Lidocaine

Interventions: Drug: Lidocaine IV
Drug: Fentanyl

First Posted Date: 2024-08-16

Last Posted Date: 2024-08-23

Lead Sponsor: Theodor Bilharz Research Institute

Target Recruit Count: 40

Registration Number: NCT06557473

Locations: 🇪🇬
Theodor Bilharz Research Institute, Giza, Egypt

Bilateral External Oblique Intercostal Plane Block in Laparoscopic Cholecystectomy

Phase 4

Completed

Conditions: Laparoscopic Cholecystectomy
External Oblique Intercostal Plane Block

Interventions: Drug: local anesthetic injection (bupivacaine)
Other: normal saline injection

First Posted Date: 2024-08-07

Last Posted Date: 2024-08-07

Lead Sponsor: Theodor Bilharz Research Institute

Target Recruit Count: 38

Registration Number: NCT06541613

Locations: 🇪🇬
Theodor Bilharz Research Institute, Giza, Egypt

Universal Stylet Bougie in Patients With Cervical Neck Immobilization.

Not Applicable

Completed

Conditions: Intubating Condition

Interventions: Device: USB as a bougie
Device: USB as a stylet

First Posted Date: 2024-07-26

Last Posted Date: 2024-07-26

Lead Sponsor: Theodor Bilharz Research Institute

Target Recruit Count: 45

Registration Number: NCT06521749

Locations: 🇪🇬
Theodor Bilharz Research Institute, Giza, Egypt

The Effects of Different Loading Doses of Dexmedetomidine on The Bispectral Index-Guided Propofol Sedation in Patients Undergoing Advanced Upper Gastrointestinal Endoscopic Procedures: A Randomized Control Study

Phase 4

Recruiting

Conditions: GIT Endoscopy
Procedural Sedation

Interventions: Drug: Precedex (Dexmedetomidine) 200 MCG in 2 ML Injection

First Posted Date: 2024-05-16

Last Posted Date: 2024-05-16

Lead Sponsor: Theodor Bilharz Research Institute

Target Recruit Count: 52

Registration Number: NCT06414395

Locations: 🇪🇬
Theodor Bilharz Research Institute, Cairo, Giza, Egypt

Effect of Dexmedetomidine on Improving Intubating Conditions Without the Use of Muscle Relaxant

Phase 4

Completed

Conditions: Intubation
Muscle Relaxation
Dexmedetomidine

Interventions: Drug: Precedex 200 MCG in 2 ML Injection

First Posted Date: 2024-05-10

Last Posted Date: 2024-05-13

Lead Sponsor: Theodor Bilharz Research Institute

Target Recruit Count: 74

Registration Number: NCT06409377

Locations: 🇪🇬
Theodor Bilharz research institute, Cairo, Egypt

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.

Recruiting

Conditions: Microbiota in Patients With Urinary Bladder Carcinoma in Urine and Cancer Tissues

First Posted Date: 2024-03-01

Last Posted Date: 2024-03-01

Lead Sponsor: Theodor Bilharz Research Institute

Target Recruit Count: 38

Registration Number: NCT06289270

Locations: 🇪🇬
Theodor Bilharz Research Institute, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy